Published online Oct 7, 2024. doi: 10.3748/wjg.v30.i37.4090
Revised: August 23, 2024
Accepted: September 12, 2024
Published online: October 7, 2024
Processing time: 170 Days and 7.2 Hours
Helicobacter pylori (H. pylori) colonizes the human stomach and many studies have discussed the mechanisms of H. pylori infection leading to gastric diseases, including gastric cancer. Additionally, increasing data have shown that the infection of H. pylori may contribute to the development of extra-gastric diseases and tumors. Inflammation, systemic immune responses, microbiome disorders, and hypergastrinemia caused by H. pylori infection are associated with many extra-gastric malignancies. This review highlights recent discoveries; discusses the relationship between H. pylori and various extra-gastric tumors, such as colorectal cancer, lung cancer, cholangiocarcinoma, and gallbladder carcinoma; and explores the mechanisms of extra-gastric carcinogenesis by H. pylori. Overall, these findings refine our understanding of the pathogenic processes of H. pylori, provide guidance for the clinical treatment and management of H. pylori-related extra-gastric tumors, and help improve prognosis.
Core Tip: Apart from gastric diseases, several studies have revealed an association between Helicobacter pylori (H. pylori) and extra-gastric diseases, including cancers. Inflammation, systemic immune responses, microbiome disorders, and hypergastrinemia caused by H. pylori may change the tumor microenvironment and eventually contribute to extra-gastric carcinogenesis. However, the research in this field remains controversial. We summarized the effects of H. pylori infection on the occurrence of extra-gastric tumors and their possible mechanisms, hoping to provide insights for clinical treatment and management of H. pylori-related extra-gastric tumors, as well as help improve prognosis.